MS vs. JNJ
Compare and contrast key facts about Morgan Stanley (MS) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MS or JNJ.
Correlation
The correlation between MS and JNJ is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MS vs. JNJ - Performance Comparison
Key characteristics
MS:
1.54
JNJ:
-0.51
MS:
2.21
JNJ:
-0.66
MS:
1.31
JNJ:
0.92
MS:
2.30
JNJ:
-0.45
MS:
9.14
JNJ:
-1.18
MS:
4.43%
JNJ:
6.71%
MS:
26.41%
JNJ:
15.44%
MS:
-88.12%
JNJ:
-52.60%
MS:
-8.15%
JNJ:
-15.81%
Fundamentals
MS:
$205.99B
JNJ:
$342.53B
MS:
$6.59
JNJ:
$6.05
MS:
19.40
JNJ:
23.52
MS:
3.63
JNJ:
0.85
MS:
$43.27B
JNJ:
$66.30B
MS:
$19.98B
JNJ:
$45.96B
MS:
$15.42B
JNJ:
$22.61B
Returns By Period
In the year-to-date period, MS achieves a -1.38% return, which is significantly lower than JNJ's -0.10% return. Over the past 10 years, MS has outperformed JNJ with an annualized return of 16.70%, while JNJ has yielded a comparatively lower 6.25% annualized return.
MS
-1.38%
-2.68%
19.79%
43.26%
22.55%
16.70%
JNJ
-0.10%
-1.47%
-1.68%
-8.22%
2.47%
6.25%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MS vs. JNJ — Risk-Adjusted Performance Rank
MS
JNJ
MS vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Morgan Stanley (MS) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MS vs. JNJ - Dividend Comparison
MS's dividend yield for the trailing twelve months is around 2.86%, less than JNJ's 3.40% yield.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Morgan Stanley | 2.86% | 2.82% | 3.49% | 3.47% | 2.14% | 2.04% | 2.54% | 2.77% | 1.72% | 1.66% | 1.73% | 0.90% |
Johnson & Johnson | 3.40% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
Drawdowns
MS vs. JNJ - Drawdown Comparison
The maximum MS drawdown since its inception was -88.12%, which is greater than JNJ's maximum drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for MS and JNJ. For additional features, visit the drawdowns tool.
Volatility
MS vs. JNJ - Volatility Comparison
Morgan Stanley (MS) has a higher volatility of 8.33% compared to Johnson & Johnson (JNJ) at 5.47%. This indicates that MS's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MS vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Morgan Stanley and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities